Charles A. Kunos Department of Radiation Oncology Summa Cancer Institute Biography Publications Institution JoVE Articles Charles A. Kunos has not added a biography. If you are Charles A. Kunos and would like to personalize this page please email our Author Liaison for assistance. Publications Determination of Triapine, a Ribonucleotide Reductase Inhibitor, in Human Plasma by Liquid Chromatography Tandem Mass Spectrometry Biomedical Chromatography : BMC. Feb, 2015 | Pubmed ID: 25677991 Two-step Procedure for Evaluating Experimentally Induced DNA Damage: Texas Red and Comet Assays Methods in Molecular Biology (Clifton, N.J.). 2015 | Pubmed ID: 25348306 Comparison and Consensus Guidelines for Delineation of Clinical Target Volume for CT- and MR-based Brachytherapy in Locally Advanced Cervical Cancer International Journal of Radiation Oncology, Biology, Physics. Oct, 2014 | Pubmed ID: 25304792 Hydration During Breast Radiotherapy May Lower Skin Toxicity The Breast Journal. Nov-Dec, 2014 | Pubmed ID: 25252223 Long-Term Disease Control with Triapine-Based Radiochemotherapy for Patients with Stage IB2-IIIB Cervical Cancer Frontiers in Oncology. 2014 | Pubmed ID: 25105092 Novel Biological Radiochemotherapy Approaches in Locally Advanced-stage Cervical Cancer Management Discovery Medicine. Apr, 2014 | Pubmed ID: 24759622 Acute Gastrointestinal Toxicity After Robotic Stereotactic Ablative Radiotherapy for Treatment of Metastatic Gynecological Malignancies Future Oncology (London, England). Feb, 2014 | Pubmed ID: 24490610 Lymphovascular Space Invasion (LVSI) is an Isolated Poor Prognostic Factor for Recurrence and Survival Among Women with Intermediate- to High-risk Early-stage Endometrioid Endometrial Cancer International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. Oct, 2013 | Pubmed ID: 24257558 Cabazitaxel-induced Stabilization of Microtubules Enhances Radiosensitivity in Ovarian Cancer Cells Frontiers in Oncology. 2013 | Pubmed ID: 24066277 Role of Stereotactic Radiosurgery in Gynecologic Cancer Current Opinion in Oncology. Sep, 2013 | Pubmed ID: 23942297 Radiation Quality, Like Art, Consists in Drawing the Line Somewhere Frontiers in Oncology. 2013 | Pubmed ID: 23882449 Radiochemotherapy Plus 3-aminopyridine-2-carboxaldehyde Thiosemicarbazone (3-AP, NSC #663249) in Advanced-stage Cervical and Vaginal Cancers Gynecologic Oncology. Jul, 2013 | Pubmed ID: 23603372 Emerging Role of Stereotactic Body Radiotherapy in the Treatment of Pancreatic Cancer Expert Review of Anticancer Therapy. Apr, 2013 | Pubmed ID: 23560842 Ribonucleotide Reductase Expression in Cervical Cancer: a Radiation Therapy Oncology Group Translational Science Analysis International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. May, 2013 | Pubmed ID: 23552804 Phase II Clinical Trial of Robotic Stereotactic Body Radiosurgery for Metastatic Gynecologic Malignancies Frontiers in Oncology. 2012 | Pubmed ID: 23227452 DNTP Supply Gene Expression Patterns After P53 Loss Cancers. Nov, 2012 | Pubmed ID: 23205301 Elevated Ribonucleotide Reductase Levels Associate with Suppressed Radiochemotherapy Response in Human Cervical Cancers International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. Nov, 2012 | Pubmed ID: 23051959 Therapeutic Mechanisms of Treatment in Cervical and Vaginal Cancer Oncology & Hematology Review. 2012 | Pubmed ID: 22943045 Hematological Toxicity After Robotic Stereotactic Body Radiosurgery for Treatment of Metastatic Gynecologic Malignancies International Journal of Radiation Oncology, Biology, Physics. Sep, 2012 | Pubmed ID: 22543208 3-アミノピリジン-2-カル チオセミカルバゾンによるメトヘモグロビン血症の管理。 Future Oncology (London, England). Feb, 2012 | Pubmed ID: 22335579 非単調データのモデルのアンサンブルの解析に。 Nucleosides, Nucleotides & Nucleic Acids. 2012 | Pubmed ID: 22303993 (18)FDG-PET/CT Definition of Clinical Target Volume for Robotic Stereotactic Body Radiosurgery Treatment of Metastatic Gynecologic Malignancies Journal of Nuclear Medicine & Radiation Therapy. Dec, 2011 | Pubmed ID: 25506042 Molecular Strategies of Deoxynucleotide Triphosphate Supply Inhibition Used in the Treatment of Gynecologic Malignancies Gynecology & Obstetrics (Sunnyvale, Calif.). Dec, 2011 | Pubmed ID: 25392744 婦人科腫瘍におけるロボット手術 Obstetrics and Gynecology International. 2011 | Pubmed ID: 22190946 進行期子宮内膜癌における化学療法と放射線療法 International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. Dec, 2011 | Pubmed ID: 21897269 デオキシヌクレオシド サルベージ リボヌクレオチド還元酵素封鎖ひと子宮頚癌中 DNA 修復を容易にします。 Radiation Research. Oct, 2011 | Pubmed ID: 21756082 感ヒトの子宮頚癌の細胞のリボヌクレオチド還元酵素を抑制することによって: 低線量率放射線応答を強化します。 International Journal of Radiation Oncology, Biology, Physics. Jul, 2011 | Pubmed ID: 21470790 低線量腹部放射線としてドセタキセル Chemosensitizer 再発卵巣がんに対する: 婦人科腫瘍グループの動態。 Gynecologic Oncology. Feb, 2011 | Pubmed ID: 21075438 次の高線量率組織内照射子宮体癌の膣拡張の遵守。 International Journal of Radiation Oncology, Biology, Physics. Jul, 2011 | Pubmed ID: 20619551 リボヌクレオチド還元酵素阻害ヒトの子宮頚癌の Chemoradiosensitivity が向上します。 Radiation Research. Nov, 2010 | Pubmed ID: 20954859 相試験骨盤の放射線、シスプラチン、3-アミノピリジン-2-カル チオセミカルバゾン (NSC #663249 3 AP) 局所進行子宮頸がんの。 Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Feb, 2010 | Pubmed ID: 20145183 放射抵抗は Virally または系沈黙 P53 蛋白発現と癌のリボヌクレオチド還元酵素を抑制することによって変調。 Radiation Research. Dec, 2009 | Pubmed ID: 19929413 放射線治療後腹膜肉腫の総合計切除に加えて結果生存期間延長: 1 つの制度的研究の結果します。 Journal of Oncology. 2008 | Pubmed ID: 19277103 トモセラピー頭蓋の放射を提供する従来の放射線対の比較。 Technology in Cancer Research & Treatment. Jun, 2008 | Pubmed ID: 18473494 注入の無料放射性種子 Mick アプリケータを用いた前立腺の腺癌のための移行。 Brachytherapy. 2004 | Pubmed ID: 15374538 定位アブレーションボディ放射線治療のための動的肺腫瘍の追跡 Charles A. Kunos1, Jeffrey M. Fabien1, John P. Shanahan1, Christine Collen2, Thierry Gevaert2, Kenneth Poels2, Robbe Van den Begin2, Benedikt Engels2, Mark De Ridder2 1Department of Radiation Oncology, Summa Cancer Institute, 2Department of Radiation Oncology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel Medicine
定位アブレーションボディ放射線治療のための動的肺腫瘍の追跡 Charles A. Kunos1, Jeffrey M. Fabien1, John P. Shanahan1, Christine Collen2, Thierry Gevaert2, Kenneth Poels2, Robbe Van den Begin2, Benedikt Engels2, Mark De Ridder2 1Department of Radiation Oncology, Summa Cancer Institute, 2Department of Radiation Oncology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel Medicine